DPW
AKRO

DiNuzzo Private Wealth’s Akero Therapeutics AKRO Stock Holding History

DiNuzzo Private Wealth’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$94 – 1371
2025
Q3 		$94 Buy
+2
New +$97 ﹤0.01% 1312

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

DiNuzzo Private Wealth's AKRO Position: Q4 2025 in Review

DiNuzzo Private Wealth sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 2 shares — an estimated $94 sold.

DiNuzzo Private Wealth first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $94 in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • DiNuzzo Private Wealth reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • DiNuzzo Private Wealth sold 2 Akero Therapeutics shares in Q4 2025, an estimated $94.
  • DiNuzzo Private Wealth first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
  • DiNuzzo Private Wealth's Akero Therapeutics position peaked at $94 in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on DiNuzzo Private Wealth's 13F filing for Q4 2025, filed 16 Jan 2026.